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INTRODUCTION
Endoscopic mucosal resection (EMR) has been widely applied for mucosal tumors of the gastrointestinal (GI) tract. Conventionally, the indications for EMR included mucosal lesions of the intestinal type no larger than 2 cm for protruded lesions, and no larger than 1 cm for depressed lesions without ulcer findings. However, since 2000, endoscopic submucosal dissection (ESD) has been applied to much larger lesions, resulting in larger artificial ulcers. The validity of ESD for large mucosal tumors has been discussed from the points of lymph node metastasis and technical problems for enbloc resection (1) (2) (3) . However, it is essential to consider the safety of this procedure on the healing process of large artificial ulcers in the postoperative period.
One major concern about ESD is that it creates artificial ulcers, and delayed bleeding has been reported in about 5% of patients (4) . Most hospitals routinely perform a second-look endoscopy to check for delayed bleeding, though there is little solid evidence to support this practice. Two reports have suggested that a second-look endoscopy after gastric ESD does not contribute significantly in the prevention of delayed bleeding (4, 5) . However, this has been held true in our experience. Therefore, we aimed to determine whether secondlook endoscopy is helpful in preventing delayed bleeding. Additionally, we analyzed the clinicopathological features of delayed bleeding to identify specific lesions that are prone to delayed bleeding.
MATERIALS and METHODS

Patients and materials
A total of 405 lesions with a histologic diagnosis of early gastric cancer (EGC) treated with ESD at our institution from January 2006 to June 2011 were retrospectively reviewed. ESD was principally indicated for possible node-negative EGCs according to the criteria established by Gotoda et al. based on chromoendoscopy with biopsy, endoscopic ultrasonographic findings and adenomas (1) . All operators were experts, and had performed atleast 100 ESDs for a period of greater than three years. Nine lesions were excluded due to perforation caused by patient-specific physiological conditions that occurred during ESD, and 4 lesions were excluded due to bleeding within 24 hours after ESD, leaving 392 EGCs (Figure 1 ). The study was approved by the Ethical Committee of the Kosin University College of Medicine.
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ESD procedures
The ESD protocol was as follows (6, 7) . Informed consent was obtained from all patients prior to treatment. Patients were required to fast the morning of the operation, which was performed under conscious sedation. An area of 5 mm outside the tumor edge was marked with an argon plasma coagulator (PSD-60, Olympus, Tokyo, Japan). Epinephrine (1:100.000 solution in saline) was injected into the submucosal layer around the lesion, and the mucosa was incised at the marks. After incising the mucosa, the lesion was dissected using an insulation tipped diathermic knife (KD-610L, Olympus, Tokyo, Japan) or Flex knife (KD-630L; Olympus, Tokyo, Japan), and all visible vessels on the ulcer floor were coagulated using hot biopsy forceps (FD-1L-1, Olympus, Tokyo, Japan). When the saline and epinephrine mixture (1:100.000) alone did not sufficiently elevate the tumor, hyaluronic acid was used. After all gastric lesions were removed, non-bleeding visible vessels and oozing were routinely treated as the final step of ESD.
Second-look and urgent endoscopies
The second-look endoscopy was performed mainly on post-operative day (POD) 2, but also was performed on POD 1 or POD 3 due to scheduling reasons. The purpose of the second-look endoscopy was to assess for recent hemorrhage or possible bleeding (non-bleeding visible vessels) at the mucosal defect. When bleeding or non-bleeding visible vessels were seen on second-look endoscopy, prophylactic hemostasis was performed. Clipping was performed with hemostatic clips (HX-610-135, Olympus, Tokyo, Japan) for large non-bleeding vessels, and thermocoagulation with hot biopsy forceps was performed for bleeding vessels, small non-bleeding vessels, or in locations that were difficult to clip due to tissue consolidation. The argon plasma coagulator was used to ablate oozing, small visible vessels or any surrounding tissue. In cases of clinically evident bleeding after ESD, an urgent endoscopy with endoscopic hemostasis on bleeding areas or non-bleeding visible vessels was performed, mainly by clipping or thermocoagulation. Blood transfusions were given to patients with hematochezia, hematemensis, or hypotension. Post-procedure, pantoprazole 40 mg per day was administered intravenously and continuously. After POD 3, one of the following proton pump inhibitors was administered orally: 20 mg rabeprazole, 40 mg omeprazole, or 30 mg lansoprazole once daily, these were considered equally effective for acid suppression (8) . Most patients resumed food intake on POD 2 just after second-look endoscopy and discharged home on POD 6 unless there was evidence of bleeding. Patients were instruct to contact their physicians in case of hematemesis or melena after discharge. When perforation or delayed bleeding occurred, the discharge schedules including food intake were changed depending on the patient's condition. The total follow-up duration was 60 days when almost all artificial ulcers were considered to have been cured (9) .
Data analysis
Delayed bleeding was defined as clinically evident bleeding including melena, hematochezia, and hematemesis, with detectable evidence of bleeding from the mucosal defect on urgent endoscopy performed 24 hours after ESD. Urgent endoscopy was F Fi ig gu ur re e 1 1. . Flowchart for analyzing the efficacy of second-look endoscopy to prevent delayed bleeding. ESD: endoscopic submucosal dissection.
defined as emergent endoscopy to control massive bleeding from the mucosal defect after ESD in the presence of hematemesis, hematochezia or melena. The following variables were analyzed to investigate factors influencing delayed bleeding: age, sex, co-morbidities (hypertension, diabetes mellitus, heart disease, chronic renal failure, and liver cirrhosis), and the use of anticoagulants and/or antiplatelet drugs (patient-related factors); the location (upper third, middle third, or lower third of the stomach), circumference (anterior wall, posterior wall, lesser curvature, or greater curvature), gross EGC type, tumor size (maximum and minimum diameter of the resected tumor), resected specimen size (maximum and minimum diameter of the resected specimen), and histologic type (EGC differentiation); the ESD period; and bleeding pattern on emergency endoscopy (spurting, oozing, exposed vessel, spot, or clots) and transfusion for postoperative bleeding. The rates of delayed bleeding before and after second-look endoscopy were investigated to determine the utility of second-look endoscopy. A flow chart analyzing the efficacy of second-look endoscopy is shown in Figure 1 .
Statistical analysis
Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS) software (version 16.0, SPSS, Chicago, IL, USA). Student's t-test was performed for age, tumor size, specimen size, and ESD period. Chi-square testing was performed to evaluate probabilities for sex, comorbidities, anticoagulant and/or antiplatelet drug use, location, circumference, gross type, and histologic differentiation. If more than one predictor with a significant difference was noted on univariate analysis, multivariate analysis using a logistic regression model was planned. An analysis of delayed bleeding was performed using the Kaplan-Meier method. Differences in the frequency of delayed bleeding before and after second-look endoscopy were studied. Statistical significance was set at a p-value of < 0.05.
RESULTS
Frequency of delayed bleeding
Delayed bleeding occurred in 12 (3,0%) of 392 lesions and was successfully managed with endoscopic treatment; no surgical intervention was required. No case of delayed bleeding experienced further rebleeding. Eight patients (66,7%) with delayed bleeding required blood transfusions. The median duration between ESD and second-look endoscopy was 2 days (range 1-3), and was performed most frequently on POD 2 (95% of second-look endoscopies). Delayed bleeding occurred less frequently after second-look endoscopy (p=0,022; Figure 2 ). Two of 60 lesions were treated with prophylactic hemostasis, and none of the 302 cases without prophylactic hemostasis showed evidence of delayed bleeding after second-look endoscopy.
Risk factor for delayed bleeding
Univariate analysis of variables predicting delayed bleeding is shown in Table 1 . Resected specimen size was the only difference noted in patients with delayed bleeding when compared with the non-bleeding groups (43,0±10,1 mm vs. 32,1±9,7 mm, p<0,001). A resected specimen size greater than 40 mm was considered a single predictor of delayed bleeding (p=0.001, odds ratio=6,200, and 95% confidence interval=1,912-20,108). The positive predictive value for delayed bleeding with a resected specimen over 40 mm was 63,8%. Multivariate analysis was not performed because univariate analysis identified only one predictor.
DISCUSSION
Two retrospective studies have suggested that second-look endoscopy to prevent delayed bleeding might be excessive or unnecessary (4, 5) . The frequencies of delayed bleeding between before and F Fi ig gu ur re e 2 2. . The frequency of delayed bleeding is significantly reduced after second-look endoscopy principally performed by postoperative day 2 (P = 0,022, Hazard Ratio = 3,763, and 95% Confidence interval = 1,211 -11,700).
after second-look endoscopy were not significantly different (4, 5) . In our study, however, more delayed bleedings occurred before second-look endoscopy than after (p=0,022).
Although treating non-bleeding visible vessels at the end of ESD did not prevent delayed bleeding completely, it seemed to reduce delayed bleeding significantly (10) . After controlling non-bleeding visible vessels, newly developing visible vessels on the ulcer bed may contribute to bleeding in some cases, which may be detected by second-look endoscopy. Second-look endoscopy did not prevent all delayed bleeding in our series, but the present study has shown that delayed bleeding decreased significantly after second-look endoscopy. However, while these findings do not prove that secondlook endoscopy is beneficial, they suggest that it may be too early to conclude that second-look endoscopy after gastric ESD contributes little to preventing delayed bleeding, especially without randomized controlled trials. Of course, the reason for such few late bleeding cases may be natural healing, and notsecond-look endoscopy.
Several studies have suggested that tumor location (10, 11) , tumor size (12) (13) (14) , and ulcerative findings (13) are independent predictive factors for delayed bleeding. When the resected specimen is over 40 mm, the risk of delayed bleeding increases *When the resected specimen is over 4 cm, the positive predictive value of delayed bleeding is 63,8%. †All anticoagulants, aspirin, warfarin, plavix, and clopidogrel, were held 7 days prior to ESD. 6,2 fold, which is in agreement with the results from a previous study (15) . Furthermore, the chance of delayed bleeding is 63.8%. Based on these findings, we suggest that endoscopists should carefully treat possible bleeding foci after ESD when removing specimens over 40 mm in size. Moreover, it is recommended that the observation period for patients with a ESD specimen size greater than 40 mm or over.
Our study has two substantial limitations. First, the predictive factor in our study was not lesion size, but specimen size. If ESD is precisely performed, specimen size should be determined by lesion size. However, practically, specimen sizes are not regularly proportional to lesion size. This might be the reason why specimen size, not lesion size, was the only predictive factor for delayed bleeding. Second, this is a retrospective study in a single center. Therefore, we cannot say that second-look endoscopy is effective for the prevention of delayed bleeding after ESD. We can only suggest that it is too early to conclusively state that second-look endoscopy is not effective.
In conclusion, based on our retrospective analysis, it is too early to judge that second-look endoscopy is not a valuable procedure. Additionally, secondlook endoscopy may be useful for preventing post-ESD bleeding, especially when the resected specimen size is over 40 mm.
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